Glucagon-like peptide 1 and appetite.

Glucagon-like peptide 1 and appetite.
复制标题

DOI:
10.1016/j.tem.2012.11.008
复制
发表时间:
2013-02
期刊:
Trends in endocrinology and metabolism: TEM
影响因子:
--
通讯作者:
Moran TH
Moran TH
中科院分区:
其他
文献类型:
--
作者:
Dailey MJ;Moran TH

文献摘要

参考文献

被引文献

相似文献

由于GLP-1模拟物在治疗II型糖尿病(T2 DM)中的成功,胰高血糖素样肽1(GLP-1)和GLP-1类似物最近受到了广泛关注,但这些化合物也可能具有治疗肥胖症的潜力。GLP-1的饱腹感效应可能涉及进餐肠-肠反射和跨餐中枢信号传导机制,以介导食欲变化并促进饱腹感。在此,我们回顾了支持外周和中枢GLP-1信号在控制胃肠动力和食物摄入中的作用的数据。了解GLP-1抑制食欲作用的机制可能有助于开发肥胖的靶向治疗。
Glucagon-like peptide 1 (GLP-1) and GLP-1 analogs have received much recent attention due to the success of GLP-1 mimetics in treating type II diabetes mellitus (T2DM), but these compounds may also have the potential to treat obesity. The satiety effect of GLP-1 may involve both meal entero-enteric reflexes and across meal central signaling mechanisms to mediate changes in appetite and promote satiety. Here, we review the data supporting the role of both peripheral and central GLP-1signaling in the control of gastrointestinal motility and food intake. Understanding the mechanisms underlying the appetite suppressive effects of GLP-1 may help in developing targeted treatments for obesity.
DOI: 10.1523/jneurosci.3262-11.2011
发表时间: 2011-10-12
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子: --
作者:
Dossat AM;Lilly N;Kay K;Williams DL
通讯作者: Williams DL
DOI: 10.1152/ajpgi.1997.273.4.g920
发表时间: 1997-10-01
影响因子: 4.5
作者:
Imeryuz, N;Yegen, BC;Ulusoy, NB
通讯作者: Ulusoy, NB
DOI: 10.1210/en.140.11.5356
发表时间: 1999-11-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Hansen, L;Deacon, CF;Holst, JJ
通讯作者: Holst, JJ
DOI: 10.1210/en.2007-1743
发表时间: 2008-08-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Hayes, Matthew R.;Skibicka, Karolina P.;Grill, Harvey J.
通讯作者: Grill, Harvey J.
DOI: 10.1210/en.137.7.2968
发表时间: 1996-07-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Bullock, BP;Heller, RS;Habener, JF
通讯作者: Habener, JF